Tirzepatide follows a predictable 2.5 mg monthly step
Gastrointestinal effects are among the most frequently reported adverse events with GLP-1 therapies and typically include nausea, vomiting, diarrhea, constipation, and abdominal pain
Warning signs of a severe allergic reaction (anaphylaxis) include: Difficulty breathing, wheezing or hoarseness Swelling of the face, lips, tongue, or throat Difficulty swallowing Rapid pulse or palpitations Dizziness or feeling faint Severe abdominal pain or vomiting Stridor (high-pitched sound when breathing) Patients should also be aware that injection site reactions including redness, itching, or swelling localised to the injection areaare relatively common with Wegovy (affecting up to 1 in 10 patients according to the SmPC) and do not necessarily indicate systemic allergy
This delivery method offers a needle-free alternative for those seeking the benefits of compounded medications like semaglutide
Proven effective, they help individuals achieve their weight loss goals by curbing excessive hunger and encouraging healthier eating habits
they should have access to these treatments